BridgeMD
MyKid-study: a study to examine the effect and safety of an injection of Mydrane® into the eye of children who will undergo cataract surgery
EU CTIS ID: 2023-504173-21-00
What this study is testing
Evaluation of the efficacy and safety of the use of Mydrane in children
- Therapeutic use (Phase IV)
A plain-language read of the study's public EU CTIS listing. The study team confirms the details.
Who can take part
You may be able to join if
- Children aged 8 weeks to 17 years old who are scheduled for surgical cataract repair of one or both eyes
You likely can't join if
- Patients with a reported allergy for one of the components of Mydrane®
- Patients younger than 8 weeks
- patients who previously had cataract surgery of one eye within this study and receive surgery of the contralateral eye on a different day
- Patients who are pregnant. Girls of childbearing age will be tested for pregnancy with urinary analysis (hCG) at the time of inclusion
The study team makes the final eligibility decision.
Questions & answers
Do participants get paid in this trial?
This listing doesn't specify compensation. Many trials still reimburse travel or offer a stipend, so it's worth asking the study team when you connect.
Is it free to join, and do I need insurance?
Searching and applying through BridgeMD is free. In clinical trials the study-related treatment and visits are generally provided at no cost to you. You usually don't need insurance to take part - confirm specifics with the study team.
How long does this study last?
The listing doesn't state an exact length. The study team walks you through the schedule and number of visits before you decide to enroll.
Who can join this trial?
This study is enrolling all sexes, 0-17 years. The study team makes the final eligibility decision.
Explore other conditions
BridgeMD is an information and trial-matching tool - not medical advice, and not the study sponsor. Details come from EU CTIS; the study team decides eligibility.